3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Other hematologic neoplasm
1
Lymphoid
1
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Urologic Neoplasms
1
Stomach Neoplasms
1
Lymphoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia
1
Head and Neck Neoplasms
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
260
fludarabine phosphate
163
Methotrexate
124
Rituximab
112
Cytarabine
109
Filgrastim
106
fludarabine
92
Busulfan
86
Peripheral Blood Stem Cell Transplantation
83
Etoposide
82
Vincristine
80
Radiotherapy
79
Tacrolimus
73
Mycophenolic Acid
72
Antilymphocyte Serum
68
Whole-Body Irradiation
66
Melphalan
63
Dexamethasone
63
Cyclosporine
58
Doxorubicin
51
Prednisone
44
Methylprednisolone
44
Alemtuzumab
44
Mercaptopurine
41
Granulocyte Colony-Stimulating Factor
40
pegaspargase
35
Daunorubicin
34
Clofarabine
33
Thiotepa
31
Asparaginase
31
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia
×
Tissue Banks
×
Lymphoid
×
Clear all
NCT06827639
2025-02-14
FUTURE
Assistance Publique Hopitaux De Marseille
Not yet recruiting
640 enrolled